Boushey CJ, Beresford SAA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascμlar disease: probable benefits of increasing folic acid intakes[J].JAMA,1995,274:1049-1057.
[2]
Eikelboom JW, Lonn E, Genest JJ, et al. Homocysteine and cardiovascμlar disease: a critical review of the epidemiologic evidence[J]. Ann Intern Med, 1999,131: 363-375.
Turhan H,Erbay AR,Yasar AS,et al.Plasma homocysteine levels in patients with isolated coronary artery ectasia[J].Cardiol,2005,104(2):158-162.
[5]
Lund G, Andersson L, Lauria M,et al. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E[J]. J Biol Chem, 2004,279(28):29147-2954.
[6]
Esteler M.CpG island methylation and histone modifications:biology and clinical significance[J].Ernst Schering Res Found Workshop,2006,(57):115-126.
[7]
Hiltunen MO, Turunen MP, H？kkinen TP, et al. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions[J].Vasc Med,2002,7(1):5-11.
[8]
Lawrence de Koning AB, Werstuck GH, Zhou J, et al.Hyperhomocysteinemia and its role in the development of atherosclerosis[J].Clin Biochem,2003,36(6):431-441.
[9]
Yan SK, Chang T, Wang H, et al.Effects of hydrogen sμlfide on homocysteine- induced oxidative stress in vascμlar smooth muscle cells[J].Biochem Biophys Res Commun,2006,351(2):485-491.
Pogribuy I,Yi P,James SJ. A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands[J].Biochem Biophys Res Commun, 1999,262(3):624-628.
